Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-076512
Filing Date
2014-02-28
Accepted
2014-02-28 14:18:27
Documents
15
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d647996d10k.htm 10-K 1080109
2 EX-11 d647996dex11.htm EX-11 18793
3 EX-21 d647996dex21.htm EX-21 1280
4 EX-23 d647996dex23.htm EX-23 1603
5 EX-31.1 d647996dex311.htm EX-31.1 9240
6 EX-31.2 d647996dex312.htm EX-31.2 9151
7 EX-32.1 d647996dex321.htm EX-32.1 4311
8 EX-32.2 d647996dex322.htm EX-32.2 3942
15 GRAPHIC g647996g05y99.jpg GRAPHIC 55669
  Complete submission text file 0001193125-14-076512.txt   8494741

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT qlti-20131231.xml EX-101.INS 1259048
10 XBRL TAXONOMY EXTENSION SCHEMA qlti-20131231.xsd EX-101.SCH 77265
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qlti-20131231_cal.xml EX-101.CAL 100468
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qlti-20131231_def.xml EX-101.DEF 242530
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE qlti-20131231_lab.xml EX-101.LAB 562867
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qlti-20131231_pre.xml EX-101.PRE 431900
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
QLT INC/BC (Filer) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17082 | Film No.: 14653928
SIC: 2834 Pharmaceutical Preparations